GIMEMAGruppo Italiano Malattie Ematologiche Ddell'Adulto (Rome, Italy)
GIMEMAGruppo Italiano Malattie e Matologiche dell'Adulto (Italian Group for Adult Hematologic Diseases)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Variant Philadelphia translocations: Molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA working party on CML analysis.
The BCR-ABL transcript levels at 3 and 6 months predict the long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib mesylate: a Gimema CML WP analysis.
Amabile et al., "Results of high dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party," Blood, vol.
(28.) Cavo M, Tacchetti P, Patriarca F, Petrucci MT, Pantani L, Galli M, et al; GIMEMA Italian Myeloma Network.
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukaemia: a joint study of the PETHEMA and GIMEMA co-operative groups.
EORTC, GIMEMA. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia.
Valsecchi, V Conter et al., "Difference in outcome of adolescents with acute lymphoblastic leukemia (ALL) enrolled in pediatric (AIEOP) and adult (GIMEMA) protocols," Blood, vol.
(3.) Cava M, Tacchetti P, Patriarca F, Petrucci MT, Pantani L, Galli M, Di Raimondo F, Crippa C, Zamagni E, Palumbo A, Offidani M, Corradini P, Narni F, Spadano A, Pescosta N, Deliliers GL, Ledda A, Cellini C, Caravita T, Tosi p, Baccarani M; GIMEMA Italian Myeloma Network.
Marzocchi et al., "Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic impact on frontline imatinib therapy: a GIMEMA Working Party on CML analysis," Blood, vol.
A recent observational database study by GIMEMA (Gruppo Italiano Malattie EMatologiche dell 'Adulto) also confirmed the utility of the index for predicting time to first treatment (16).